文献速递系统性红斑狼疮

美国医疗补助系统性红斑狼疮人群中新起始羟氯喹治疗患者的基线视网膜检查(2000-2010年)

Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-01

研究利用账单编码识别2000至2010年美国29个人口最多州的医疗补助系统性红斑狼疮患者,纳入12755例新起始羟氯喹治疗者,评估基线视网膜检查比例。结果显示32.5%接受基线散瞳眼底检查,2000至2010年比例无显著变化(31.0-34.4%;线性趋势P=0.12)。女性、亚裔相对白人及前一年实验室检查次数较多与检查可能性增加相关;黑人和美洲原住民患者接受检查比例低于白人。

要点

  • 新起始羟氯喹治疗的医疗补助系统性红斑狼疮患者中仅32.5%接受基线散瞳眼底检查。
  • 2000至2010年基线眼底检查比例无显著变化(31.0-34.4%;线性趋势P=0.12)。
  • 黑人和美洲原住民患者基线视网膜检查比例低于白人患者。

核心结论

  • 仅三分之一的医疗补助系统性红斑狼疮新起始羟氯喹治疗患者接受了推荐的基线视网膜检查,且该比例从2000至2010年无显著增加。
  • 这种推荐诊疗中的社会人口学差异在系统性红斑狼疮其他推荐医疗中也曾观察到,需要进一步调查和干预加以解决。

研究设计与样本

  • 利用账单编码识别2000至2010年居住在美国29个人口最多州、年龄18-65岁、参加医疗补助的系统性红斑狼疮患者。
  • 新使用羟氯喹者定义为有已配药处方且前12个月内无任何已配药处方。
  • 基线视网膜检查定义为索引处方前30天至后1年内进行的检查。
  • 采用双变量和多变量逻辑回归模型比较接受与未接受检查患者的特征。

主要发现

  • 在12755例新起始羟氯喹治疗的系统性红斑狼疮患者中,32.5%接受了基线散瞳眼底检查。
  • 2000至2010年接受基线眼底检查的患者比例无显著变化(31.0-34.4%;线性趋势P=0.12)。
  • 与检查可能性增加相关的因素包括女性、亚裔相对白人种族以及前一年进行的实验室检查次数较多。
  • 与白人患者相比,黑人和美洲原住民系统性红斑狼疮患者接受基线视网膜检查的比例较低。

关键数值与推荐

  • 基线视网膜检查:索引处方前30天至后1年内进行。
  • 新使用羟氯喹:有已配药处方且前12个月内无已配药处方。
  • 接受基线散瞳眼底检查比例:32.5%(12755例中)。
  • 2000至2010年基线眼底检查比例范围:31.0-34.4%;线性趋势P=0.12。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Baseline retinal examinations have long been recommended for patients beginning treatment with hydroxychloroquine (HCQ), but it is unknown how well this guideline is followed. We investigated baseline eye examinations among US SLE patients enrolled in Medicaid in whom HCQ treatment was newly initiated. METHODS: Using billing codes, we identified SLE patients ages 18-65 years who were enrolled in Medicaid and residing in the 29 most populated US states, from 2000 to 2010. New users of HCQ were identified by filled prescriptions, with none filled in the preceding 12 months. Retinal examinations that were performed within 30 days before to 1 year after the index prescription were identified. We examined the proportions of patients receiving retinal examinations over the study years and compared the characteristics of those who did and those who did not receive examinations, using bivariable and multivariable logistic regression models. RESULTS: Among 12,755 SLE patients newly starting HCQ treatment, 32.5% received baseline dilated eye examinations. The proportions of patients receiving baseline eye examinations did not significantly change from 2000 to 2010 (31.0-34.4%; P for linear trend = 0.12). Factors associated with an increased likelihood of having an examination included female sex, Asian versus white race, and a higher number of laboratory tests performed during the preceding year. Compared with white patients, lower proportions of black and Native American patients with SLE had baseline retinal examinations. CONCLUSION: Only one-third of patients with SLE enrolled in Medicaid and in whom HCQ was newly initiated received the recommended baseline retinal examinations, and this proportion did not significantly increase from 2000 to 2010. The sociodemographic variation in this recommended care has been observed for other recommended medical care in SLE and requires both further investigation and interventions to address it.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Lin TC, Marmor MF, Barbhaiya M, et al. Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010. Arthritis Care Res (Hoboken). 2018. PMID: 29409142. doi:10.1002/acr.23530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。